If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carlo Genova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Exome Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Population Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2020

  • 21 Citations
  • 3 h-Index
  • 18 Article
  • 5 Review article

Liquid biopsy in non-small cell lung cancer: Highlights and challenges

Rijavec, E., Coco, S., Genova, C., Rossi, G., Longo, L. & Grossi, F., Jan 2020, In : Cancers. 12, 1, 17.

Research output: Contribution to journalReview article

Open Access
6 Citations (Scopus)

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., Cortinovis, D., Pilotto, S., Landi, L., Bennati, C., Camerini, A., Toschi, L., Putzu, C., Cerea, G., Spitaleri, G., Cappuzzo, F. & 1 others, de Marinis, F., Mar 1 2019, In : Clinical Lung Cancer. 20, 2, p. e186-e194

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Mutation
Exons
Point Mutation

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence

Ricciuti, B., Genova, C., Crinò, L., Libra, M. & Leonardi, G. C., 2019, In : OncoTargets and Therapy. 12, p. 3171-3179 9 p.

Research output: Contribution to journalArticle

Gene Fusion
Neoplasms
High-Throughput Nucleotide Sequencing
Genetic Translocation
Phase II Clinical Trials

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Carbone, F., Grossi, F., Bonaventura, A., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Biello, F., Rossi, G., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Oct 15 2019, In : Clinical and Experimental Metastasis. 36, 5, p. 449-456 8 p.

Research output: Contribution to journalArticle

Osteopontin
Non-Small Cell Lung Carcinoma
Serum
Therapeutics
C-Reactive Protein

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Rossi, G., Bauckneht, M., Genova, C., Rijavec, E., Biello, F., Mennella, S., Dal Bello, M. G., Cittadini, G., Bruzzi, P., Piva, R., Ceriani, V., Sambuceti, G., Lopci, E., Morbelli, S. & Grossi, F., Dec 5 2019, In : Journal of Nuclear Medicine.

Research output: Contribution to journalArticle